RSS

Tag Archive | "Genentech"

Tarceva Cauases hepatic failure and hepatorenal syndrome

Tuesday, November 18, 2008

0 Comments

Tarceva (erlotinib) – Cases of hepatic failure and hepatorenal syndrome, including fatalities, have been reported during use of Tarceva Tarceva (erlotinib) Tablets Audience: Oncological healthcare professionals OSI and Genentech notified healthcare professionals that cases of hepatic failure and hepatorenal syndrome, including fatalities, have been reported during use of Tarceva, particularly in patients with baseline hepatic […]

Continue reading...

Avastin and sunitinib malate- Bad Combination!

Monday, July 14, 2008

0 Comments

Reports of Microangiopathic Hemolytic Anemia In Patients Treated With This Combination Genentech, Inc. informed healthcare professionals of reports of several cases of microangiopathic hemolytic anemia (MAHA) in patients with solid tumors receiving Avastin in combination with sunitinib malate. Avastin is not approved for use in combination with sunitinib malate and this combination is not recommended. […]

Continue reading...

Damaged and broken vials of Herceptin 440 mg and BWFI

Thursday, July 10, 2008

0 Comments

Genentech informed healthcare professionals that an increased number of complaints were received regarding damaged and broken vials of Herceptin 440 mg and BWFI (bacteriostatic water for injection) diluent. The affected vials are NDC# 50242-0134-68, List # 15534. There is a risk that damaged vials may lead to a loss in sterility, which can cause infections […]

Continue reading...